|
|||||
|
A Harvard bioengineer and an MIT aeronautical engineer have created a new device that can detect single cancer cells in a blood sample, potentially allowing doctors to quickly determine whether cancer has spread from its original site. The microfluidic device, described in the March 17 online edition of the journal Small, is about . . . → Read More: MIT: New Blood-testing Device Can Quickly Spot Cancer Cells, HIV Eating green leafy vegetables “significantly lowers the risk” of oral cancer among women who smoke, a recent study has revealed. The research showed for every one serving of green leafy vegetables, the risk of oral cancer for current women smokers is reduced compared to those who have given up or never smoked. . . . → Read More: Eat Your Greens To Reduce The Risk Of Oral Cancer NeoProteomics Inc., a biomarker development and software company, has secured an exclusive option agreement with Case Western Reserve University. The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases. Proteomics is the scientific next step in vital research of protein structures of biological systems. NeoProteomics, founded in . . . → Read More: Proteomics Research Heading Towards Personalized Treatments For Cancer, Diabetes And Inflammatory Diseases The American Association for Cancer Research (AACR) has announced that Carey Anders, MD, assistant professor of medicine and a member of UNC Lineberger Comprehensive Cancer Center will receive a Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research. The $181,000 grant will be presented at the organization’s 102nd Annual Meeting, to be held . . . → Read More: Carey Anders, MD, UNC Physician-Scientist Receives Grant To Study Breast Cancer Brain Metastases A research team at the University of Colorado Cancer Center has identified an enzyme that could be used to diagnose colon cancer earlier. It is possible that this enzyme also could be a key to stopping the cancer. Colon cancer is the third most common cancer in Americans, with a one in 20 chance . . . → Read More: University Of Colorado Team Identifies New Colon Cancer Marker In a new review article published in yesterday’s special section of Science focusing on the past forty years since the U.S. declared “War on Cancer,” three Cancer Research Institute scientists describe how advances in the field of tumor immunology have revealed a complex and paradoxical relationship between cancer and the immune system, and discuss . . . → Read More: New Perspectives On Cancer And The Immune System Gentel Biosciences, a leader in proteomics tools, and Van Andel Research Institute (VARI), a biomedical research institute, have jointly announced the granting of U.S. Patent 7,838,634 for a new method to profile changes in the glycosylation of proteins captured on the surface of an antibody array slide. Gentel first obtained an exclusive right to . . . → Read More: Early Detection And Prognosis Of Cancer Improved By New Technology Researchers exploring human metabolism at the University of California, San Francisco (UCSF) have uncovered a handful of chemical compounds that regulate fat storage in worms, offering a new tool for understanding obesity and finding future treatments for diseases associated with obesity. As described in a paper published this month in the journal Nature . . . → Read More: “Worm Screening” In Obesity Study, A Way Of Finding New Targets For Human Diseases Research led by Daitoku Sakamuro, PhD, Assistant Professor of Pathology at LSU Health Sciences Center New Orleans and the LSUHSC Stanley S. Scott Cancer Center, has identified a protein that enables the activation of a DNA-repair enzyme that protects cancer cells from catastrophic damage caused by chemo and radiation therapy. This protein, called . . . → Read More: Protein That Protects Cancer Cells From Chemo And Radiation Therapy Discovered By LSUHSC Research Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published in the March issue of the International Journal of Radiation Oncology-Biology-Physics, an official journal of . . . → Read More: Radiation Combined With Statin Use More Effective At Curing Prostate Cancer It’s been nearly 10 years since Beth Israel Deaconess Medical Center (BIDMC) scientists Kun Ping Lu, MD, PhD and Xiao Zhen Zhou, MD, discovered PinX1, the first potent endogenous protein shown to inhibit telomerase in mammals. Now the scientific team has discovered a vitally important new function for this telomerase inhibitor. The . . . → Read More: First Genetic Evidence To Link Telomerase Activation To Chromosomal Instability A new catalytic chemical method for the synthesis of a large and important class of carbon-carbon double bonds has been developed by scientists from Boston College and MIT, the team reports in the journal Nature. The findings substantially expand the versatility of a set of metal-based catalysts discovered only three years ago by the . . . → Read More: Special Versatility Of New Catalytic Method Has Implications For Alzheimer’s, Cancer, Autoimmune Disease Research Researchers at Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine (VIMM) have discovered a novel mechanism in gene regulation that contributes to the development of a form of liver cancer called hepatocellular carcinoma (HCC). Currently, there is virtually no effective treatment for HCC, and this breakthrough identifies a promising new . . . → Read More: Discovery In Liver Cancer Cells Provides New Target For Drugs Princeton researchers have invented an extremely sensitive sensor that opens up new ways to detect a wide range of substances, from tell-tale signs of cancer to hidden explosives. The sensor, which is the most sensitive of its kind to date, relies on a completely new architecture and fabrication technique developed by the Princeton . . . → Read More: Breakthrough In Ultra-Sensitive Sensor Technology Cancer Research UK scientists have found that counting the number of lung cancer cells circulating in the blood could determine how aggressive the cancer is and predict the best treatment to use. The research, published today in the Journal of Clinical Oncology1, looked at the number of circulating tumour cells (CTCs) in blood . . . → Read More: Counting Lung Cancer Cells Opens Window On Disease |
|||||
|
Copyright © 2012 Biomed Middle East - All Rights Reserved |
|||||
